AGP Picks
View all

Health Professional Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Professional Times.

Press releases published on July 30, 2026

SodaSlim Official Launch 2026 Natural Weight Loss Capsules For metabolic and appetite support in USA. Soda Slim Highlights Ingredient and Supplement Facts
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
Medical Oncology Software Market to Reach US$ 7.5 Billion by 2033 at 6.6% CAGR | Persistence Market Research
Women's Health Diagnostics Market to Reach US$ 47.1 Billion at 5.9% CAGR by 2033 | Persistence Market Research
Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.
FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
Cellectis to Report Second Quarter Financial Results on August 6, 2026
Cellectis publiera ses résultats financiers du deuxième trimestre jeudi 6 août 2026
STERIS Raises Dividend to $0.69 per share
Following Recent FDA Advisory Discussions, PepMD Reaffirms Commitment to Clinical Standards and Research
LERRA Clinic Advances Digital Dentistry in Istanbul with Innovative Technology and International Care
Voting Rights and Shares Capital of the Company
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
CooperCompanies Announces Release Date for Third Quarter 2026
DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound
Red Sift launches new email defense integrations for Claude and ChatGPT
GenomOncology Announces Integrated End-to-End Workflow Using PacBio’s Long-Read Whole-Genome Sequencing Technology in Oncology
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Professional Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.